F514-0191 Screening compound: N-(3-phenylpropyl)-3-[5-(piperidine-1-sulfonyl)-1H-1,2,3-benzotriazol-1-yl]propanamide

F514-0191 Screening compound: N-(3-phenylpropyl)-3-[5-(piperidine-1-sulfonyl)-1H-1,2,3-benzotriazol-1-yl]propanamide
F514-0191 Screening compound: N-(3-phenylpropyl)-3-[5-(piperidine-1-sulfonyl)-1H-1,2,3-benzotriazol-1-yl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F514-0191
N-(3-phenylpropyl)-3-[5-(piperidine-1-sulfonyl)-1H-1,2,3-benzotriazol-1-yl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F514-0191

Molecular Formula

C23H29N5O3S (C23 H29 N5 O3 S)

Compound Name

N-(3-phenylpropyl)-3-[5-(piperidine-1-sulfonyl)-1H-1,2,3-benzotriazol-1-yl]propanamide

IUPAC name

N-(3-phenylpropyl)-3-[5-(piperidine-1-sulfonyl)-1H-123-benzotriazol-1-yl]propanamide

SMILES

O=C(CCn1nnc2c1ccc(S(N1CCCCC1)(=O)=O)c2)NCCCc1ccccc1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

455.58

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.893

Distribution Coefficient, logD

2.893

Water Solubility, LogSw

-3.45

Polar Surface Area

81.667

Acid Dissociation Constant (pKa)

14.53

Base Dissociation Constant (pKb)

1.37

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

43.50

F514-0191 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Lipid Metabolism Library (9174 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cardiovascular
  • Metabolic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F514-0191 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F514-0191?
Check Price and Availability of F514-0191, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F514-0191 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F514-0191
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F514-0191
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F514-0191 available by request